Long-Term Major Adverse Cardiovascular Events in Patients "Appropriately" Tested for Troponin Assays in Emergency
Ahmed Hassaan Qavi1, Soban Ahmad2, Mian Tanveer Ud Din3
1Department of Cardiovascular Sciences, East Carolina University, Greenville, NC.
Judicious troponin testing in the emergency department (ED) is crucial. Inappropriate testing for acute coronary syndrome (ACS) biomarkers increases major adverse cardiac events (MACE) risk and overdiagnosis.
Area of Science:
- Cardiology
- Emergency Medicine
- Clinical Diagnostics
Background:
- Troponin testing is vital for diagnosing myocardial ischemia in acute coronary syndrome (ACS) in the emergency department (ED).
- However, overuse of troponin tests leads to false positives, patient anxiety, and unnecessary interventions.
Purpose of the Study:
- To establish appropriateness criteria for troponin testing in the ED.
- To evaluate the long-term major adverse cardiac events (MACE) associated with troponin testing.
Main Methods:
- Retrospective analysis of 407 patients undergoing troponin testing at a tertiary-care hospital.
- Categorization of troponin tests as appropriate or inappropriate based on established criteria.
- Long-term follow-up (over 540 days) to track MACE.
Main Results:
- 62% of troponin tests were deemed appropriate; 38% were inappropriate.
- Higher MACE rates were observed in the appropriate testing group (21%) compared to the inappropriate group (10%).
- Appropriate testing was associated with an increased adjusted risk of MACE (HR 2.55).
Conclusions:
- Judicious troponin testing is supported by these findings.
- Robust appropriateness criteria are necessary to prevent overdiagnosis and inappropriate testing in the ED.
- Optimizing troponin test ordering can improve patient outcomes and resource utilization.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction
Cardiac Catheterization I: Pre-Procedure Overview
Angina III: Clinical Manifestations and Assessment
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
